InsidersTradesSigma
Total declarations
Company
▲ Purchases (22 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
22
Disclosed sells
0
T+90 hit rate
58%
T+90 mean return
+24.0%
Across 33 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Young Caroline, Director. Officer active across 1 company, notably Cumberland Pharmaceuticals INC. Cumulatively, 38 filings have been logged. Breakdown: 22 buys · 0 sell. Total volume traded: €852. Activity tracked since 17 March 2021. The latest transaction was filed on 1 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations38 total
4 shares@ US$4.86Common StockSEC:0001628280-25-029852:0
Ideal exit: 26 Jan 2026 (T+270)
4 shares@ US$4.240.1% of flowCommon StockSEC:0001628280-25-024355:0
Ideal exit: 27 Dec 2025 (T+270)
4 shares@ US$5.540.1% of flowCommon StockSEC:0001628280-25-016745:0
Ideal exit: 28 Nov 2025 (T+270)
1,000 shares@ US$5.1721.9% of flowCommon StockSEC:0001628280-25-013548:0
2,500 shares@ US$1.7118.2% of flowCommon StockSEC:0001628280-25-003181:0
15 shares@ US$1.330.1% of flowCommon StockSEC:0001628280-24-052610:0
Ideal exit: 29 Aug 2025 (T+270)
38 shares@ US$1.150.2% of flowCommon StockSEC:0001628280-24-050113:0
Ideal exit: 29 Jul 2025 (T+270)
31 shares@ US$1.270.2% of flowCommon StockSEC:0001628280-24-045334:0
Ideal exit: 28 Jun 2025 (T+270)
25 shares@ US$1.380.1% of flowCommon StockSEC:0001628280-24-042124:0
21 shares@ US$1.470.1% of flowCommon StockSEC:0001214659-24-016075:0
21 shares@ US$1.470.1% of flowCommon StockSEC:0001214659-24-016035:0
21 shares@ US$1.470.1% of flowCommon StockSEC:0001214659-24-013685:0
25 shares@ US$1.520.2% of flowCommon StockSEC:0001214659-24-011873:0
1,000 shares@ US$1.717.3% of flowCommon StockSEC:0001214659-24-005221:0
72 shares@ US$1.690.5% of flowCommon StockSEC:0001214659-23-017033:0
55 shares@ US$1.850.4% of flowCommon StockSEC:0001214659-23-016104:0
55 shares@ US$1.890.5% of flowCommon StockSEC:0001214659-23-014544:0
65 shares@ US$1.680.5% of flowCommon StockSEC:0001214659-23-013096:0
65 shares@ US$1.640.5% of flowCommon StockSEC:0001214659-23-012221:0
1,000 shares@ US$1.978.4% of flowCommon StockSEC:0001209191-23-021276:0
20 shares@ US$2.530.2% of flowCommon StockSEC:0001209191-22-062647:0
Ideal exit: 29 Jul 2023 (T+270)
20 shares@ US$2.330.2% of flowCommon StockSEC:0001209191-22-062657:0
Ideal exit: 28 Aug 2023 (T+270)
20 shares@ US$2.570.2% of flowCommon StockSEC:0001209191-22-057947:0
Ideal exit: 24 Jun 2023 (T+270)
20 shares@ US$2.350.2% of flowCommon StockSEC:0001209191-22-051671:0
Ideal exit: 13 May 2023 (T+270)
20 shares@ US$2.110.2% of flowCommon StockSEC:0001209191-22-046900:0
Ideal exit: 28 Mar 2023 (T+270)
25 of 38 declarations
About Young Caroline
Caroline Young is associated with CUMBERLAND PHARMACEUTICALS INC.
